Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-08-10
Lerman Bradley E Files McKesson (MCK) Form 4 - August 10, 2026
Lerman Bradley E sold 301 MCK shares worth $268.6K in this Form 4 filing, reported to the SEC on 2026-08-10.
- Insider
- Lerman Bradley E
- Issuer
- McKesson Corporation MCK · NYSE
- Filed
- Period
- 2026-08-10
- Accession
- 0000927653-26-000239
- Source
- Official filing on sec.gov ↗
Transactions (1)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Lerman Bradley E | 2026-08-10 | Sell | 301 | $892.33 | $268.6K | Direct |
| Net change | −301 | −$268.6K | ||||
About McKesson Corporation
McKesson Corporation is a leading healthcare services and information technology company. It plays a crucial role in the distribution of pharmaceuticals and medical products. The primary function of McKesson is to ensure the efficient delivery of healthcare products to pharmacies, hospitals, and other medical facilities, ensuring that millions of patients have access to the medications they need. It also provides specialized software and automated solutions that enhance operational efficiency in healthcare sectors. McKesson significantly impacts the pharmaceutical and healthcare industries by offering solutions that streamline supply chains and improve patient care. Its services encompass wholesale drug distribution, healthcare IT systems, and pharmacy management. With operations that extend globally, McKesson is integral to maintaining the integrity and reliability of healthcare supply networks. By handling a substantial portion of the pharmaceutical distribution in North America, McKesson Corporation has a vital market presence, emphasizing its importance in shaping healthcare logistics and innovation. Its efforts contribute to advancing healthcare delivery and responding to the evolving demands of the medical industry.
Track MCK insider activity
Get alerted when McKesson Corporation executives buy or sell their shares.